205 related articles for article (PubMed ID: 3490495)
21. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
Clutterbuck E; Shields JG; Gordon J; Smith SH; Boyd A; Callard RE; Campbell HD; Young IG; Sanderson CJ
Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a T4+/Leu-8+ T cell clone that directly helps B cell Ig production by secreting B cell differentiation factor.
Goldstein H; Volkman DJ; Ambrus JL; Fauci AS
J Immunol; 1985 Jul; 135(1):339-43. PubMed ID: 3923106
[TBL] [Abstract][Full Text] [Related]
24. Production of B cell growth factor by normal human B cells.
Jurgensen CH; Ambrus JL; Fauci AS
J Immunol; 1986 Jun; 136(12):4542-7. PubMed ID: 3519772
[TBL] [Abstract][Full Text] [Related]
25. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
26. Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors.
Tadmori W; Lee HK; Clark SC; Choi YS
J Immunol; 1989 Feb; 142(3):826-32. PubMed ID: 2783602
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
[TBL] [Abstract][Full Text] [Related]
28. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
Yoshizaki K; Nakagawa T; Kaieda T; Muraguchi A; Yamamura Y; Kishimoto T
J Immunol; 1982 Mar; 128(3):1296-301. PubMed ID: 6799573
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
Bowen DL; Ambrus JL; Fauci AS
J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
[TBL] [Abstract][Full Text] [Related]
31. Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.
Clark EA; Shu G
J Immunol; 1987 Feb; 138(3):720-5. PubMed ID: 3492530
[TBL] [Abstract][Full Text] [Related]
32. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
[TBL] [Abstract][Full Text] [Related]
33. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
34. Signal requirements for growth and differentiation of activated murine B lymphocytes.
Müller W; Kühn R; Goldmann W; Tesch H; Smith FI; Radbruch A; Rajewsky K
J Immunol; 1985 Aug; 135(2):1213-9. PubMed ID: 3874233
[TBL] [Abstract][Full Text] [Related]
35. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
[TBL] [Abstract][Full Text] [Related]
36. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
Butler JL; Ambrus JL; Fauci AS
J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
[TBL] [Abstract][Full Text] [Related]
37. Functional properties of two human B cell growth factor species separated by lectin affinity column.
Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
[TBL] [Abstract][Full Text] [Related]
38. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
39. Human cell lines secreting lymphokines. I. Establishment of T-T hybridomas.
Epstein N; Gozes Y; Halmann M; Kobiler D
Dev Biol Stand; 1987; 66():439-46. PubMed ID: 3108054
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.
Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K
J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
